<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04201730</url>
  </required_header>
  <id_info>
    <org_study_id>KY2018-396</org_study_id>
    <nct_id>NCT04201730</nct_id>
  </id_info>
  <brief_title>Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer</brief_title>
  <official_title>A Single Center, Open, Randomized Clinical Trial：Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huashan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, there are more and more reports about enhanced recovery after surgery（ERAS）in
      China, but there is no ERAS treatment standard for gastrointestinal cancer, and there are
      many factors limiting the development of ERAS. In recent years, due to the development of
      minimally invasive technology, the establishment of evidence-based medicine model and the
      development of MDT, it makes a good solid foundation for the clinical application of ERAS.
      The implementation of ERAS requires the cooperation of surgeons, anesthesia management,
      nursing, rehabilitation and other teams. As an individualized treatment mode, ERAS focuses on
      the optimization of treatment for different individuals in order to acquire the best benefit
      of patients. Therefore, the concept of ERAS is still in the process of continuous improvement
      and development in China, hoping to explore the Chinese ERAS clinical pathway for
      gastrointestinal cancer. The purpose of this study is to optimize the clinical pathway of
      ERAS in the perioperative period of gastrointestinal cancer, and to evaluate the
      effectiveness and safety of ERAS in gastrointestinal cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 25, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospitalization Days</measure>
    <time_frame>Postoperative up to 2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of getting out of bed after operation</measure>
    <time_frame>Postoperative 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The time to first flatus</measure>
    <time_frame>Postoperative 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Expenses on medical treatment, medicine and hospitalization</measure>
    <time_frame>On discharge, Postoperative up to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative complications</measure>
    <time_frame>Postoperative 3 months、6 months、1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Enhanced Recovery After Surgery</condition>
  <condition>Gastrointestinal Cancer</condition>
  <arm_group>
    <arm_group_label>ERAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perioperative intervention with individual Enhanced Recovery After Surgery （ERAS）</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enhanced Recovery After Surgery （ERAS）</intervention_name>
    <description>Preoperative education，Preoperative nutritional support，Preoperative bowel preparation，Preventative applying of antibiotics，Intraoperative warming，Goal-directed fluid therapy，Postoperative analgesia，Postoperative diet, drainage and activity management，Prevention of deep vein thrombosis.</description>
    <arm_group_label>ERAS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign the informed consent

          -  Preoperative pathology confirmed gastric cancer or colorectal cancer

          -  Age: 18-70 years, men or women

          -  According to NCCN guidelines, it is not Stage IV tumor

          -  Perform radical gastrectomy or radical colon cancer surgery (CME) or radical rectal
             cancer surgery (TME);

          -  ASA I-III

          -  Receive no radiotherapy or chemotherapy before operation

          -  The subjects can describe the symptoms objectively and keep the follow-up plan

        Exclusion Criteria:

          -  Preoperative pathology confirmed no gastric cancer / no colorectal cancer (such as
             rectal neuroendocrine tumor, lymphoma, etc.)

          -  Stage IV or Radical resection can't be performed

          -  Emergency operation

          -  Can't cooperate with clinical data collection

          -  General condition is intolerable to operation

          -  Serious diseases, including heart function ≥ level II, respiratory function
             insufficiency, liver and kidney function insufficiency, and blood system diseases

          -  Patients participate in other clinical trials at the same time

          -  Pregnant or perinatal women

          -  Other malignant tumors

          -  History of mental illness

          -  Had a history of severe trauma within 4 weeks before admission

          -  Less than 6 months after other level 4 operations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Huashan Hospital Affiliated to Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianbin Xiang, doctor</last_name>
      <phone>86-21-52887333</phone>
      <email>68875417@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiaodong Gu, doctor</last_name>
      <phone>86-21-52887333</phone>
      <email>gxdgxd737@sohu.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jianbin Xiang, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. Review.</citation>
    <PMID>11222424</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee SM, Kang SB, Jang JH, Park JS, Hong S, Lee TG, Ahn S. Early rehabilitation versus conventional care after laparoscopic rectal surgery: a prospective, randomized, controlled trial. Surg Endosc. 2013 Oct;27(10):3902-9. doi: 10.1007/s00464-013-3006-4. Epub 2013 May 25.</citation>
    <PMID>23708720</PMID>
  </results_reference>
  <results_reference>
    <citation>Kehlet H. Fast-track surgery-an update on physiological care principles to enhance recovery. Langenbecks Arch Surg. 2011 Jun;396(5):585-90. doi: 10.1007/s00423-011-0790-y. Epub 2011 Apr 6. Review.</citation>
    <PMID>21468643</PMID>
  </results_reference>
  <results_reference>
    <citation>Aarts MA, Okrainec A, Glicksman A, Pearsall E, Victor JC, McLeod RS. Adoption of enhanced recovery after surgery (ERAS) strategies for colorectal surgery at academic teaching hospitals and impact on total length of hospital stay. Surg Endosc. 2012 Feb;26(2):442-50. doi: 10.1007/s00464-011-1897-5. Epub 2011 Oct 20. Review.</citation>
    <PMID>22011937</PMID>
  </results_reference>
  <results_reference>
    <citation>Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition. 2012 Oct;28(10):1022-7. doi: 10.1016/j.nut.2012.01.017. Epub 2012 Jun 5.</citation>
    <PMID>22673593</PMID>
  </results_reference>
  <results_reference>
    <citation>Li P, Fang F, Cai JX, Tang D, Li QG, Wang DR. Fast-track rehabilitation vs conventional care in laparoscopic colorectal resection for colorectal malignancy: a meta-analysis. World J Gastroenterol. 2013 Dec 21;19(47):9119-26. doi: 10.3748/wjg.v19.i47.9119. Review.</citation>
    <PMID>24379639</PMID>
  </results_reference>
  <results_reference>
    <citation>Li YJ, Huo TT, Xing J, An JZ, Han ZY, Liu XN, Zhao QC. Meta-analysis of efficacy and safety of fast-track surgery in gastrectomy for gastric cancer. World J Surg. 2014 Dec;38(12):3142-51. doi: 10.1007/s00268-014-2690-0. Review.</citation>
    <PMID>25228170</PMID>
  </results_reference>
  <results_reference>
    <citation>Spanjersberg WR, van Sambeeck JD, Bremers A, Rosman C, van Laarhoven CJ. Systematic review and meta-analysis for laparoscopic versus open colon surgery with or without an ERAS programme. Surg Endosc. 2015 Dec;29(12):3443-53. doi: 10.1007/s00464-015-4148-3. Epub 2015 Mar 24. Review.</citation>
    <PMID>25801106</PMID>
  </results_reference>
  <results_reference>
    <citation>Ni TG, Yang HT, Zhang H, Meng HP, Li B. Enhanced recovery after surgery programs in patients undergoing hepatectomy: A meta-analysis. World J Gastroenterol. 2015 Aug 14;21(30):9209-16. doi: 10.3748/wjg.v21.i30.9209. Review.</citation>
    <PMID>26290648</PMID>
  </results_reference>
  <results_reference>
    <citation>Sammour T, Zargar-Shoshtari K, Bhat A, Kahokehr A, Hill AG. A programme of Enhanced Recovery After Surgery (ERAS) is a cost-effective intervention in elective colonic surgery. N Z Med J. 2010 Jul 30;123(1319):61-70.</citation>
    <PMID>20717178</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2019</study_first_posted>
  <last_update_submitted>December 25, 2019</last_update_submitted>
  <last_update_submitted_qc>December 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huashan Hospital</investigator_affiliation>
    <investigator_full_name>Jianbin Xiang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

